MasterControl appoints David Edwards as CEO to drive next phase of growth MasterControl appoints David Edwards as CEO to drive next phase of growth Former CEO Jon Beckstrand Appointed Chairman of the Board; Prior Chair and Salt Lake City Business Pioneer Richard Beckstrand Transitions to Board Member Quibim appoints Itta MacNevin as Chief Business Officer to accelerate global growth and life sciences partnerships Quibim appoints Itta MacNevin as Chief Business Officer to accelerate global growth and life sciences partnerships Quibim, the global pioneer in imaging biomarkers for precision medicine, is pleased to announce the appointment of Itta MacNevin as Chief Business Officer (CBO). The... Resyca announces the appointment of Deborah Jones as CEO Resyca announces the appointment of Deborah Jones as CEO Dr Jones brings more than 20 years of executive leadership experience driving commercial growth in life sciences technology companies Germfree appoints Chief Executive Officer Germfree appoints Chief Executive Officer Carol Houts brings 30 years of healthcare and life sciences leadership to Germfree’s next phase of growth and execution Saharsh Davuluri to take over as CEO & MD of Neuland and lead the next phase of CDMO expansion Saharsh Davuluri to take over as CEO & MD of Neuland and lead the next phase of CDMO expansion Announcement follows several years of stellar growth and points to a sharper focus on expanding commercial NCE opportunities Sygnature Discovery strengthens in vivo pharmacology leadership with appointment of Susanne Back Sygnature Discovery strengthens in vivo pharmacology leadership with appointment of Susanne Back The appointment of Susanne Back as Head of In Vivo Pharmacology will further strengthen its bioscience leadership and reinforcing its commitment to delivering high-quality,... BioDuro appoints Dr. Andrew Thomas and Dr. Stevan Djuric as Scientific Advisors BioDuro appoints Dr. Andrew Thomas and Dr. Stevan Djuric as Scientific Advisors Industry leaders bring decades of pharmaceutical R&D leadership to support BioDuro’s global innovation and clients’ programs FUJIFILM Biotechnologies Appoints Christiane Bardroff as Chief Business Officer FUJIFILM Biotechnologies Appoints Christiane Bardroff as Chief Business Officer FUJIFILM Biotechnologies, a world-leading contract development and manufacturing organisation (CDMO) for biologics, vaccines, and advanced therapies, announced the appointment... Envair Technology appoints new sales director to accelerate global growth Envair Technology appoints new sales director to accelerate global growth Orders up 20% year on year as demand for clean air solutions increases across higher education, pharma and healthcare sectors Kindeva appoints Mike Cowhig as Chief Legal Officer Kindeva appoints Mike Cowhig as Chief Legal Officer The appointment will drive legal strategy, enterprise risk management and corporate governance across the organisation EyeC enters Brazilian market with first-time exhibition at ExpoPrint & ConverFlexo EyeC enters Brazilian market with first-time exhibition at ExpoPrint & ConverFlexo Appointment of local regional manager strengthens support for Latin America’s print and packaging industry OSE Immunotherapeutics confirms Marc Le Bozec as chief executive officer OSE Immunotherapeutics confirms Marc Le Bozec as chief executive officer Le Bozec to lead next phase of strategic growth and accelerate patient access to breakthrough therapies Ardena appoints Paul Edwards as Chief People Officer Ardena appoints Paul Edwards as Chief People Officer Paul Edwards will lead Ardena’s global people strategy, strengthening organisational capability and supporting the company’s continued international growth Ensorcell appoints biopharma industry veterans Geoff Hodge and Amy Teachout to Senior Leadership Team Ensorcell appoints biopharma industry veterans Geoff Hodge and Amy Teachout to Senior Leadership Team Geoff Hodge named Head of Technology; Amy Teachout appointed Head of Customer Excellence eXmoor Pharma appoints new chief commercial officer eXmoor Pharma appoints new chief commercial officer Manuel Balbuena to lead global commercial strategy and expand client partnerships SeaBeLife welcomes Professor Eric Souied to its scientific committee SeaBeLife welcomes Professor Eric Souied to its scientific committee He will guide the scientific focus of SeaBeLife’s ophthalmological program, the only one currently targeting two key forms of programmed cell death: necroptosis and ferroptosis